Pfizer Says U.S. to Buy 10 Million More Courses of Paxlovid (2)

Jan. 4, 2022, 7:55 PM UTC

Pfizer Inc. said the U.S. government has agreed to buy an additional 10 million courses of its Covid-19 pill, adding to the country’s stash of virus-fighting tools as infections continue to rise.

The company said in a statement on Tuesday that the U.S. agreed to buy the additional supply of the drug, known as Paxlovid, on top of 10 million courses it had previously agreed to purchase. About 10 million courses have been accelerated for delivery by the end of June, Pfizer said, with the remaining tranche to be delivered by the end of September.

Pfizer shares were down 2.8% ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.